茵栀黄口服液联合双歧杆菌四联活菌治疗新生儿黄疸的效果分析

王洁洁; 王国凯

doi:10.16766/j.cnki.issn.1674-4152.002547

茵栀黄口服液联合双歧杆菌四联活菌治疗新生儿黄疸的效果分析

doi: 10.16766/j.cnki.issn.1674-4152.002547

王洁洁,
王国凯^,

安徽中医药大学第一附属医院儿科，安徽合肥 230000

基金项目:

安徽省高校优秀青年人才支持计划重点项目 gxyqZD2019035

详细信息

通讯作者:
王国凯, E-mail: wanggk@ahtcm.edu.cn

中图分类号: R722.17 R985
计量
- 文章访问数: 310
- HTML全文浏览量: 80
- PDF下载量: 1
- 被引次数: 0
出版历程
- 收稿日期: 2021-06-22
- 网络出版日期: 2022-09-23

Analysis of the curative effect of Yinzhihuang oral liquid combined with bifidobacterium tetragenous viable bacteria in the treatment of neonatal jaundice

WANG Jie-jie,
WANG Guo-kai^,

Department of Pediatrics, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui 230000, China

摘要

摘要: 目的评估联合应用双歧杆菌四联活菌片、茵栀黄口服液治疗新生儿黄疸的疗效及安全性。方法选取2019年5月—2020年12月安徽中医药大学第一附属医院住院新生儿黄疸患儿50例，采用随机数字表法分为观察组和对照组，每组各25例。2组均给予蓝光光疗、肝酶诱导剂苯巴比妥口服的常规治疗，对照组给予常规治疗+双歧杆菌四联活菌0.5 g温水冲服，3次/d，观察组给予常规治疗+双歧杆菌四联活菌0.5 g，温水冲服，3次/d，茵栀黄口服液5 mL，口服，3次/d。对比2组治疗前后血清总胆红素、直接胆红素、间接胆红素水平、不良反应发生率、光疗总时间、光疗总费用、住院时间。结果治疗前2组总胆红素、直接胆红素、间接胆红素比较差异无统计学意义(均P＞0.05)。治疗后2组直接胆红素比较差异无统计学意义(P＞0.05)。治疗后观察组血清总胆红素为(118.78±23.43)μmol/L，间接胆红素为(106.89±22.39)μmol/L，显著低于对照组[(135.41±28.66)μmol/L、(123.31±27.77)μmol/L，均P＜0.05]。观察组不良反应发生率为4.00%(1/25)，对照组为24.00%(6/25)，2组比较差异无统计学意义(P＞0.05)。观察组光疗总时间、光疗总费用、住院时间均显著低于对照组(均P＜0.05)。结论新生儿黄疸在常规治疗基础上，联合应用双歧杆菌四联活菌、茵栀黄口服液，临床疗效显著，可减少住院时间，降低光疗费用，是安全、有效的治疗方法。
- 新生儿黄疸 /
- 双歧杆菌四联活菌 /
- 茵栀黄口服液 /
- /
Abstract: Objective To evaluate the efficacy and safety of the combined application of bifidobacterium tetragenous viable bacteria and Yinzhihuang oral liquid in the treatment of neonatal jaundice. Methods Total 50 patients with neonatal jaundice in the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine from May 2019 to December 2020 were selected and randomly divided into control and observation groups, with 25 cases in each group. Both groups were treated with blue light phototherapy and oral administration of liver enzyme inducer phenobarbital. The control group was treated with conventional treatment + bifidobacterium tetragenous viable bacteria 0.5 g with warm water three times/day. On the basis of the control group, the observation group was treated with Yinzhihuang oral liquid 5 mL/time, oral, 3 times/d. The differences of various indexes between the two groups before and after treatment were compared. Results There was no significant difference in total bilirubin, direct bilirubin and indirect bilirubin between the two groups before treatment (all P > 0.05). After treatment, there was no significant difference in indirect bilirubin between the two groups (P > 0.05), meanwhile, the total bilirubin and indirect bilirubin of the observation group [(118.78±23.43) and (106.89±22.39) μmol/L] were significantly lower than those of the control group [(135.41±28.66) and (123.31±27.77) μmol/L, all P < 0.05]. The incidence of adverse reactions in the observation group was 4.00% (1/25), and that in the control group was 24.00% (6/25). There was no statistically significant difference between the two groups (P > 0.05). The total time of phototherapy, the total cost of phototherapy and the length of stay in the observation group were significantly lower than those in the control group, and the difference was statistically significant (all P < 0.05). Conclusion On the basis of conventional treatment for neonatal jaundice, the combined application of bifidobacterium tetragenous viable bacteria and Yinzhihuang oral liquid has a significant clinical effect, reduces hospitalisation time and the cost of phototherapy, and is a safe and effective treatment method.
- Neonatal jaundice /
- Bifidobacterium quadruple /
- Live bacteria /
- Yinzhihuang oral liquid /
- Curative effect

HTML全文

表 1 2组新生儿黄疸患儿治疗前后血清总胆红素、直接胆红素、间接胆红比较(x±s，μmol/L)

Table 1. The comparison of serum total bilirubin, direct bilirubin and indirect bilirubin between the two groups before and after treatment

组别	例数	总胆红素		间接胆红素		直接胆红素
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
对照组	25	243.64±32.87	135.41±28.66^a	231.92±32.42	123.31±27.77^a	11.95±2.37	12.09±1.90
观察组	25	256.90±32.35	118.78±23.43^a	244.14±31.28	106.89±22.39^a	12.75±2.50	11.90±2.49
t值		-1.437	2.247	-1.256	2.301	-1.162	0.310
P值		0.157	0.029	0.181	0.026	0.251	0.758
注：与同组治疗前比较，^aP＜0.05。

下载: 导出CSV

表 2 2组新生儿黄疸患儿光疗时间、住院时间、光疗费用比较(x±s，μmol/L)

Table 2. Phototherapy time, hospitalization time and phototherapy cost of two groups of neonatal jaundice

组别	例数	光疗时间(h)	住院时间(d)	光疗费用(元)
对照组	25	35.28±11.13	4.64±0.64	749.90±237.47
观察组	25	28.80±10.82	4.12±0.93	611.79±230.39
t值		2.087	2.310	2.087
P值		0.042	0.025	0.042

下载: 导出CSV

参考文献(24)

[1]	陈萍. 益生菌和维生素B₂结合蓝光治疗新生儿高胆红素血症的疗效观察及分析[J]. 贵州医药, 2019, 43(6): 941-942. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201906038.htm CHEN P. Effects of probiotics and vitamin B2 combined with blue light on neonatal hyperbilirubinemia effect observation and analysis[J]. Guizhou Medical Journal, 2019, 43(6): 941-942. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201906038.htm
[2]	IWATANI S, BURGESS J, KALISH F, et al. Bilirubin production is increased in newborn nice exposed to isoflurane[J]. Neonatology, 2019, 115(1): 21-27. doi: 10.1159/000492421
[3]	SLUSHER T M, ZAMORA T G, APPIAH D, et al. Burden of severe neonatal jaundice: A systematic review and meta-analysis[J]. BMJ Paediatr Open, 2017, 1(1): e000105. DOI: 10.1136/bmjpo-2017-000105.
[4]	0LUSANYA B O, KAPLAN M, HANSEN T W R. Neonatal hyperbilirubinaemia: A global perspective[J]. Lancet Child Adolesc Health, 2018, 2(8): 610-620. doi: 10.1016/S2352-4642(18)30139-1
[5]	陈芳芳, 李崇寿, 倪王平. 间隙和持续蓝光照射治疗新生儿黄疸的临床效果研究[J]. 中国保健营养, 2019, 29(1): 126-127. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201202025.htm CHEN F F, LI C S, NI W P. Effect of intermittent and continuous blue light irradiation on neonatal jaundice Clinical effect research[J]. 中国保健营养, 2019, 29(1): 126-127. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201202025.htm
[6]	麦静仪, 饶晓林. 早期不同蓝光照射方案治疗新生儿黄疸的效果及安全性观察[J]. 现代诊断与治疗, 2020, 31(1): 91-92. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD202001048.htm MAI J Y, RAO X L. Effect of different blue light irradiation schemes on neonatal jaundice and safety observatio[J]. Modern Diagnosis and Treatment, 2020, 31(1): 91-92. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD202001048.htm
[7]	袁丽君. 新生黄疸患儿行LED冷光源与常规蓝光光疗的治疗效果及其不良反应[J]. 临床研究, 2020, 28(1): 125-126. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY201919026.htm YUAN L J. Therapeutic effect of LED cold light source and conventional blue light therapy on neonatal jaundice and its adverse reactions[J]. Clinical Research, 2020, 28(1): 125-126. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY201919026.htm
[8]	王卫平, 孙锟. 儿科学[M]. 北京: 人民卫生出版社, 2018: 112-114. WANG W P, SUN K. Pediatrics[M]. Beijing: People's Health Publishing House, 2018: 112-114.
[9]	国家中医药管理局. 中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》——胎黄的诊断依据、证候分类、疗效评定(ZY/T001.1-94)[J]. 辽宁中医药大学学报, 2017, 19(10): 131. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201710043.htm The State Administration of traditional Chinese medicine. Chinese medicine industry standard of the people's Republic of China Criteria for diagnosis and curative effect of disease and syndrome - diagnostic basis, syndrome classification and curative effect evaluation of fetal yellow (ZY /T001.1-94)[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2017, 19(10): 131. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201710043.htm
[10]	VITEK L. Bilirubin as a signaling molecule[J]. Med Res Rev, 2020, 40(4): 1335-1351. doi: 10.1002/med.21660
[11]	HANSEN T W R, WONG R J, STRVENSON D K. Molecular physiology and pathophysiology of bilirubin handling by the blood, liver, intestine, and brain in the newborn[J]. Physiol Rev, 2020, 100(3): 1291-1346. doi: 10.1152/physrev.00004.2019
[12]	张士发, 茅双根. 新生儿黄疸的诊断与治疗[J]. 中华全科医学, 2016, 14(7): 1064-1065. http://www.zhqkyx.net/article/id/98724073-8741-49c7-90bd-02b7011b82fc ZHANG S F, MAO S G. Diagnosis and treatment of neonatal jaundice[J]. Chinese Journal of General Practice, 2016, 14(7): 1064-1065. http://www.zhqkyx.net/article/id/98724073-8741-49c7-90bd-02b7011b82fc
[13]	LAI K, SONG X L, SHI H S, et al. Bilirubin enhances the activity of ASIC channels to exacerbate neurotoxicity in neonatal hyperbilirubinemia in mice[J]. Sci Transl Med, 2020, 12(530): eaax1337. DOI: 10.1126/scitranslmed.aax1337.
[14]	申艳泉. 观察间隙和持续蓝光光疗对新生儿病理性黄疸的临床治疗效果[J]. 中国社区医师, 2019, 35(16): 65. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS201916045.htm SHEN Y Q. Clinical observation of intermittent and continuous blue light phototherapy on neonatal pathological jaundice therapeutic effect[J]. Chinese Community Physicians, 2019, 35(16): 65. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS201916045.htm
[15]	LI Y B, ZHOU W, YYAN W M, et al. Composition of gut microbiome in neonates with severe hyperbilirubinemia and its effect on bilirubin brain injury[J]. Chin J Appl Clin Pediatr, 2018, 33(2): 103-107.
[16]	DONG T, CHEN T, WHITE R, et al. Meconium microbiome associates with the development of neonatal jaundice[J]. Clin Transl Gastroenterol, 2018, 9(9): 182. doi: 10.1038/s41424-018-0048-x
[17]	YANG N, YANG R X, WANG A H, et al. The effect of intestinal flora on the neural development of severe hyperbilirubinemia neonates[J]. Eur Rev Med Pharmacol Sci, 2019, 23(3): 1291-1295.
[18]	胡文文. 双歧杆菌四联活菌片联合蓝光治疗新生儿高胆红素血症的临床疗效[J]. 中国处方药, 2020, 18(2): 64-65. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF202002037.htm HU W W. Treatment of neonatal hyperbilirubinemia with Bifidobacterium tetra viable tablets combined with blue light[J]. Chinese Prescription Drugs, 2020, 18(2): 64-65. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF202002037.htm
[19]	徐桂林. 双歧杆菌四联活菌片辅助蓝光照射治疗新生儿黄疸的疗效观察[J]. 现代诊断与治疗, 2017, 28(19): 3674-3675. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD201719092.htm XU G L. Treatment of neonatal jaundice with Bifidobacterium tetra viable tablets assisted by blue light irradiation curative effect observation[J]. Modern Diagnosis and Treatment, 2017, 28(19): 3674-3675. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZD201719092.htm
[20]	聂小红. 间隙蓝光照射联合双歧杆菌四联活菌片治疗新生儿黄疸的临床效果[J]. 中外医学研究, 2019, 17(6): 151-152. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201906073.htm NIE X H. Intermittent blue light irradiation combined with Bifidobacterium tetra live tablets in the treatment of neonatal jaundice clinical effect of jaundice[J]. Chinese and Foreign Medical Research, 2019, 17(6): 151-152. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201906073.htm
[21]	刘玉萍, 邱小玉, 刘烨, 等. 茵陈的药理作用研究进展[J]. 中草药, 2019, 50(9): 228-234. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201909033.htm LIU Y P, QIU X Y, LIU Y, et al. Research progress on pharmacological action of Artemisia capillaris[J]. Chinese Traditional and Herbal Drugs, 2019, 50(9): 228-234. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201909033.htm
[22]	罗菁, 卢洪萍. 茵栀黄口服液联合培菲康对新生儿黄疸的疗效及对T细胞亚群的影响[J]. 中华全科医学, 2017, 15(3): 463-465. doi: 10.16766/j.cnki.issn.1674-4152.2017.03.031 LUO J, LU H P. Clinical effect and influence on T cell subsets of Yinzhihuang oral solution combined Bifico in patients with neonatal jaundice[J]. Chinese Journal of General Practice, 2017, 15(3): 463-465. doi: 10.16766/j.cnki.issn.1674-4152.2017.03.031
[23]	田艳华, 高永伟, 张永娇, 等. 蓝光间歇照射与蓝光持续照射辅助黄疸茵陈颗粒治疗新生儿黄疸疗效分析[J]. 山西医药杂志, 2019, 48(17): 2152-2153. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201917030.htm TIAN Y H, GAO Y W, ZHANG Y J, et al. Intermittent blue light irradiation and continuous blue light irradiation analysis of curative effect of jaundice Yinchen Granule on neonatal jaundice[J]. Shanxi Medical Journal, 2019, 48(17): 2152-2153. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201917030.htm
[24]	韩姗姗, 陈文霞, 苏素静, 等. 基于GRADE系统的茵栀黄口服液联合常规疗法治疗新生儿黄疸的循证分析[J]. 中成药, 2019, 41(2): 321-326. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201902016.htm HAN S S, CHEN W X, SU J, et al. Evidence-based analysis of Yinzhihuang Oral Liquid combined with conventional therapy in treating neonatal jaundice based on GRADE system[J]. Chinese Traditional Patent Medicine, 2019, 41(2): 321-326. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201902016.htm